Publications

2022年

1. Inhibitory effect of α1 receptor antagonists on paclitaxel-induced peripheral neuropathy in a rodent model and clinical database.
Mori K, Kawashiri T, Mine K, Inoue M, Kudamatsu H, Uchida M, Egashira N, Kobayashi D, Shimazoe T.
Toxics. 2022;10(11):669.

2. Omeprazole suppresses oxaliplatin-induced peripheral neuropathy in a rodent model and clinical database.
Mine K, Kawashiri T, Inoue M, Kobayashi D, Mori K, Hiromoto S, Kudamatsu H, Uchida M, Egashira N, Koyanagi S, Ohdo S, Shimazoe T.
Int J Mol Sci. 2022;23(16):8859.

3. Analysis of the thinking process of pharmacists in response to changes in the dispensing environment using the eye-tracking method.
Tsuji T, Nagata K, Sasaki K, Matsukane R, Ishida S, Kawashiri T, Suetsugu K, Watanabe H, Hirota T, Ieiri I.
J Pharm Health Care Sci. 2022;8(1):23.

4. Effect of sokeikakketsuto combined with interventional treatment on low back pain - a case report.
Nakamura H, Uchida M, Miyamae Y, Kurata S, Shin K, Kobayashi D, Kawashiri T, Shimazoe T.
JOJ Case Stud. 2022;13(4):555869.

5. Time to onset of bendamustine-associated skin damage using the spontaneous reporting system.
Kashiwagi M, Shimizu T, Kawai R, Kawashiri T, Uesawa Y, Uchida M.
Anticancer Res. 2022;42(5):2737-2741.

6. Safety and efficacy of dietary freshwater clam (Corbicula fluminea) extract in clinical research.
Shimazoe T, Kobayashi D, Kawashiri T, Chijimatsu T, Umeki M, Mochizuki S.
Funct Foods Health Dis. 2022;12(6):325-339

7. Evaluation of medication Instruction sheets for patients undergoing R-CHOP therapy in non-Hodgkin's lymphoma.
Uchida M, Kawai R, Hisamitsu R, Mai S, Ishida S, Watanabe H, Kawashiri T, Kato K, Hosohata K, Miyamoto T, Egashira N, Nakamura T, Akashi K, Ieiri I.
In Vivo. 2022;36(3):1461-1467.

8. Usefulness of medication guidance sheets for patients with non-Hodgkin's lymphoma receiving ESHAP±R therapy.
Uchida M, Murata S, Morikawa H, Yonemitsu H, Ishida S, Suetsugu K, Tsuji T, Watanabe H, Kawashiri T, Kato K, Hosohata K, Miyamoto T, Egashira N, Nakamura T, Akashi K, Ieiri I.
Anticancer Res. 2022;42(4):2053-2060.

9. Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big date.
Zamami Y*, Niimura T*, Kawashiri T*, Goda M, Naito Y, Fukushima K, Ushio S, Aizawa F, Hamano H, Okada N, Yagi K, Miyata K, Takechi K, Chuma M, Koyama T, Kobayashi D, Shimazoe T, Fujino H, Izawa-Ishizawa Y, Ishizawa K. (*equal contribution)
Biomed Pharmacother. 2022;148:112744.

10. Mechanisms and safety of antidepressant-like effect of nutmeg in mice.
Iwata N, Kobayashi D, Kawashiri T, Kubota T, Kawano K, Yamamuro Y, Miyagi A, Deguchi Y, Chijimatsu T, Shimazoe T.
Biol Pharm Bull. 2022;45(6):738-742.


2021年

1.Preclinical and clinical evidence of therapeutic agents for paclitaxel-induced peripheral neuropathy.
Kawashiri T, Inoue M, Mori K, Kobayashi D, Mine K, Ushio S, Kudamatsu H, Uchida M, Egashira N, Shimazoe T.
Int J Mol Sci.2021;22(16):8733.

2. Analysis of secondary leukemia and myelodysplastic syndrome after chemotherapy for solid organ tumors using the Food and Drug Administration Adverse Event Reporting System (FAERS).
Kawashiri T, Kobayashi D, Uchida M, Hiromoto S, Inoue M, Ikeda H, Inoue M, Shimazoe T.
J Pharm Pharm Sci.2021;24:499-508.

3. Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats.
Egashira N, Goto Y, Takahashi R, Iba H, Yamamoto S, Watanabe T, Kubota K, Kawashiri T, Taniguchi C, Katsurabayashi S, Iwasaki K.
J Pharmacol Sci.2021;147(1):114-117.

4. Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome.
Hiromoto S, Kawashiri T, Yamanaka N, Kobayashi D, Mine K, Inoue M, Uchida M, Shimazoe T.
Sci Rep. 12021;1(1):8964.

5. Therapeutic agents for oxaliplatin-induced peripheral neuropathy; experimental and clinical evidence.
Kawashiri T, Mine K, Kobayashi D, Inoue M, Ushio S, Uchida M, Egashira N, Shimazoe T.
Int J Mol Sci. 2021;22(3):1393.

6. Analgesic effects of Sokeikakketsuto on chemotherapy-induced mechanical allodynia and cold hyperalgesia in rats.
Nakamura H, Kawashiri T, Kobayashi D, Uchida M, Egashira N, Shimazoe T.
Biol Pharm Bull. 2021;44(2):271-274.

7. Pharmacovigilance evaluation of bendamustine-related skin disorders using the Japanese Adverse Drug Event Report database.
Uchida M, Kawashiri T, Maegawa N, Takano A, Hosohata K, Uesawa Y.
J Pharm Pharm Sci. 2021;24:16-22.


2020年

1. Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents.
Kawashiri T, Kobayashi D, Egashira N, Tsuchiya T, Shimazoe T.
Sci Rep.2020;10(1):12665.

2. Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro.
Shigematsu N*, Kawashiri T*, Kobayashi D, Shimizu S, Mine K, Hiromoto S, Uchida M, Egashira N, Shimazoe T. (*equal contribution)
Sci Rep.2020;10(1):6734.

3. Need for prescription suggestions for long-term inpatients in the psychiatric ward.
Shin K, Kobayashi D, Kawashiri T, Ushijima Y, Moritaka K, Yanai H, Ichiki Y, Murakami A, Kanazawa Y, Kamimura H, Shimazoe T.
Yakugaku Zasshi. 2020;140(8):1025-1033.

4. Assessing the efficacy of a tongue image analyzing system (TIAS) for the objective diagnosis of static blood: an observational, retrospective, single-centre study of Japanese Kampo Medicine.
Kainuma M, Matsumura C, Kawashiri T, Kobayashi D, Murakami A, Nakaguchi T, Namiki T, Shimazoe T.
Trad Kampo Med. 2020;7(3):146-152.

5. Effects of diluent volume and administration time on the incidence of anaphylaxis following docetaxel therapy in breast cancer.
Ishida S, Masuguchi K, Kawashiri T, Tsuji T, Watanabe H, Akiyoshi S, Kubo M, Masuda S, Egashira N.
Biol Pharm Bull. 2020;43(4):663-668.

6. Anti-tumor activities of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and bisphosphonates in pancreatic cell lines which show poor responses to gemcitabine.
Kawashiri T, Tokunaga A, Kobayashi D, Shimazoe T.
Biol Pharm Bull. 2020;43(1):49-52.

7. 新規抗てんかん薬血中濃度測定の内製化による効果
末次 王卓, 山本 奈々絵, 重松 智博, 小林 大介, 土谷 祐一, 中山 由理恵, 辻 敏和, 渡邊 裕之, 金谷 朗子, 増田 智先, 江頭 伸昭
薬学雑誌,2020;140(8):1035-1040.

8. 医療薬学研究の最先端 薬系大学における医療薬学系研究者の育成とその展望
川尻 雄大, 小林 大介, 家入 一郎
月刊薬事,2020;62:135-140.


2019年

1. Donepezil ameliorates oxaliplatin-induced peripheral neuropathy via a neuroprotective effect
Kawashiri T, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe T
J Pharmacol Sci. 2019;140:291-294.

2. Promoting patient care through communication training in a pre-clerkship pharmacy education course in Japan.
Epp DA, Kubota T, Yoshida M, Kishimoto J, Kobayashi D, Shimazoe T.
Am J Pharm Educ.2019;83:6745.

3. Dimethyl fumarate attenuates oxaliplatin-induced peripheral neuropathy without affecting the anti-tumor activity of oxaliplatin in rodents
Miyagi A*, Kawashiri T*, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe T.(*equal contribution)
Biol Pharm Bull. 2019;42:638-644. 

4. 電子診療録へのスタンプ貼付によるベンゾジアゼピン受容体作動薬減薬の取り組みとその評価
進 健司, 小林 大介, 川尻 雄大, 猪狩 圭介, 光安 博志, 村上 智哉, 堤 一樹, 金澤 康範, 神村 英利, 島添 隆雄
薬学雑誌, 2019 139:1449–1456

5. 精神科外来における診察前薬剤師面談の患者による評価
進 健司,小林 大介,川尻 雄大,牛島 悠一,梅田 勇一,金澤 康範,神村 英利,島添 隆雄
薬学雑誌, 2019 2:317-325

6. 抗がん薬による末梢神経障害の回避を目指した新たなアプローチ
川尻 雄大
日本薬理学雑誌, 2019;153:200.


2018年

1. Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro.
Kawashiri T, Miyagi A, Shimizu S, Shigematsu N, Kobayashi D, Shimazoe T.
J Pharmacol Sci. 2018;137(2):202-211.

2. Interindividual Differences in the Expression of ATP-Binding Cassette and Solute Carrier Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 Gene.
Takechi T, Hirota T, Sakai T, Maeda N, Kobayashi D, Ieiri I.
Drug Metab Dispos. 2018;46(5):628-635.

3. 節薬バッグ運動における残薬確認による処方調整の 効果及び薬効別服薬アドヒアランスの評価
小林 大介、小柳 香織、窪田 敏夫、坂本 佳子、木原 太郎、三井所 尊正、加﨑 哲夫、國武 雅弘、竹下 文明、安東 恵津子、馬場 智弘、瀬尾 隆、田中 泰三、島添 隆雄
薬学雑誌, 2018, 138:1313-1322.

4. 節薬バッグ運動における服用時点別服薬状況スコアを用いた服薬アドヒアランス向上の評価
小林 大介, 小栁 香織, 窪田 敏夫, 丸山 真実, 三井所 尊正, 金子 絵里奈, 川浪 望恵, 木原 太郎, 髙木 淳一, 中芝 高彦, 永冨 茂, 瀬尾 隆, 田中 泰三, 島添 隆雄
薬学雑誌, 2018, 138, 1549-1559.


2017年

1. Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug
Yamamoto S, Ushio S, Egashira N, Kawashiri T, Mitsuyasu S, Higuchi H, Ozawa N, Masuguchi K, Ono Y, Masuda S.
Sci Rep. 2017;7(1):9661

2. Evaluation of teicoplanin trough values after the recommended loading dose in children with associated safety analysis.
Yamada T, Kubota T, Yonezawa M, Nishio H, Kanno S, Yano T, Kobayashi D, Egashira N, Takada H, Hara T, Masuda S.
Pediatr Infect Dis J. 2017;36(4):398-400.

3. C型肝炎ウイルスに対する直接作用型抗ウイルス薬による血清脂質の変化
吉澤 裕子, 石田 茂, 川尻 雄大, 南 晴奈, 益口 賢, 齊藤 麻美, 渡邊 裕之, 江頭 伸昭, 古庄 憲浩, 増田 智先
九州薬学会会報, 2017:71:45-50.

4. 喉頭摘出者の術後症状の理解度及び安心感に対する薬剤師による教育の効果
俵口 奈穂美,窪田 敏夫,小林 大介,島添 隆雄
薬学雑誌, 2017;137(1):83-93.

5. 薬剤師の在宅医療推進のための症例検討プログラムの構築 教育と臨床の融合 在宅医療における症例検討の役割と教育的効果
大澤 友二, 島添 隆雄
薬学雑誌, 2017:137(8):947-956.

6.残薬調整から医薬品の適正処方・適正使用へつなげる
島添 隆雄
日本薬剤師会雑誌, 2017;69(4).

7.「節薬バッグ運動」一般社団法人福岡市薬剤師会と九州大学の連携による成果
島添 隆雄
ふくおか県薬会報, 2017;30(4):213.


2016年

1. Bioelectrical impedance Analysis (BIA) of the association of the Japanese Kampo concept "Suidoku" (fluid disturbance) and the body composition of women.
Murakami A, Kobayashi D, Kubota T, Zukeyama N, Mukae H, Furusyo N, Kainuma M, Shimazoe T.
BMC Complement Altern Med. 2016;16(1):405.

2. Heart rate variability as a predictor of the outcome of treatment with kampo medicines that include Bupleuri Radix (Saiko).
Murakami A, Kubota T, Kobayashi D, Sumoto Y, Furusyo N, Ando S, Kainuma M, Shimazoe T.
Res Rev Pharm Pharm Sci. 2016:5(4);1-8.

3. Prescription factors associated with medication non-adherence in Japan assessed from leftover drugs in the SETSUYAKU-BAG campaign: focus on oral antidiabetic drugs.
Koyanagi K, Kubota T, Kobayashi D, Kihara T, Yoshida T, Miisho T, Miura T, Sakamoto Y, Takaki J, Seo T, Shimazoe T.
Front Pharmacol.2016;7:212.

4. The relation between hepatotoxicity and the total coumarin intake from traditional Japanese medicines containing cinnamon bark.
Iwata N, Kainuma M, Kobayashi D, Kubota T, Sugawara N, Uchida A, Ozono S, Yamamuro Y, Furusyo N, Ueda K, Tahara E, Shimazoe T.
Front Pharmacol.2016;7:174.

5. Effects on deaf patients of medication education by pharmacists.
Hyoguchi N, Kobayashi D, Kubota T, Shimazoe T.
J Deaf Stud Deaf Educ. 2016;21(4):416-421.

6. Synergistic antiproliferative effects of zoledronic acid and fluvastatin on human pancreatic cancer cell lines: an in vitro study.
Elsayed M, Kobayashi D, Kubota T, Matsunaga N, Murata R, Yoshizawa Y, Watanabe N, Matsuura T, Tsurudome Y, Ogino T, Ohdo S, Shimazoe T.
Biol Pharm Bull. 2016;39(8):1238-1246.

7. Effect of patient education for diabetic outpatients by a hospital pharmacist: a retrospective study.
Ichiki Y, Kobayashi D, Kubota T, Ozono S, Murakami A, Yamakawa Y, Zeki K, Shimazoe T.
Yakugaku Zasshi. 2016;136(12):1667-1674.


2014年

1. Maternal exposure to dioxin imprints sexual immaturity of the pups through fixing the status of the reduced expression of hypothalamic gonadotropin-releasing hormone.
Takeda T, Fujii M, Hattori Y, Yamamoto M, Shimazoe T, Ishii Y, Himeno M, Yamada H.
Mol Pharmacol. 2014;85(1):74-82.

2. Evaluation of teicoplanin concentrations and safety analysis in neonates.
Yamada T, Kubota T, Nakamura M, Ochiai M, Yonezawa M, Yano T, Kawashiri T, Egashira N, Hara T, Masuda S.
Int J Antimicrob Agents. 2014;44(5):458-62.

3. 採用医薬品数の削減と後発品医薬品の採用促進の取り組みとその評価 ―削除薬アンケートと薬剤師主導による1増2減システムについて―,
一木 裕子, 小林 大介, 窪田 敏夫, 島添 隆雄
日本病院薬剤師会雑誌, 2014;50(4):479-484.


2013年

1. Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.
Okamoto R, Itoh Y, Murata Y, Kobayashi D, Hosoi M, Mine K.
Pharmacology. 2013;91(3-4):145-152.

2. Severe sleepiness and excess sleep duration induced by paroxetine treatment is a beneficial pharmacological effect, not an adverse reaction.
Murata Y, Kamishioiri Y, Tanaka K, Sugimoto H, Sakamoto S, Kobayashi D, Mine K.
J Affect Disord. 2013;150(3):1209-1212.

3. Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placenta.
Saito J, Hirota T, Furuta S, Kobayashi D, Takane H, Ieiri I.
PLoS One. 2013;8(8):e72906.

4. 節薬バッグ運動 外来患者の残薬の現状とその有効活用による医療費削減の取組み
小栁 香織, 窪田 敏夫, 小林 大介, 木原 太郎, 吉田武夫, 三井所 尊正, 斎藤 友亮, 打越 英恵, 髙木 淳一, 瀬尾隆, 島添 隆雄
薬学雑誌, 2013;133(11):1215-1221.

5. 初年度薬局実務実習の服薬指導実習に対する学生の視点による改善点の検討
窪田 敏夫、小林 大介、西村 京子、岩切 詩子、島添隆雄
医学教育, 2013;44(5):327-334.

6. 大学病院における実務実習の改善とその評価
國分 千代, 窪田 敏夫, 園田 正信, 江頭 伸昭, 大石了三
九州薬学会会報, 2013;67:65-68.


2012年

1. Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial.
Ohnaka K, Ikeda M, Maki T, Okada T, Shimazoe T, Adachi M, Nomura M, Takayanagi R, Kono S.
J Nutr Metab. 2012;2012:207426.

2. Simplified dosing regimens of teicoplanin for patient groups stratified by renal function and weight using Monte Carlo simulation.
Yamada T, Nonaka T, Yano T, Kubota T, Egashira N, Kawashiri T, Oishi R.
Int J Antimicrob Agents. 2012;40(4):344-348.

3. がん患者に対する服薬指導の留意事項 非がん患者との比較解析
岩切 詩子, 小林 大介, 窪田 敏夫, 末永 啓二, 神村英利, 島添 隆雄
癌と化学療法, 2012;39(11):1693-1697.


2011年

1. Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function.
Sasaki T, Hirota T, Ryokai Y, Kobayashi D, Kimura M, Irie S, Higuchi S, Ieiri I.
Drug Metab Pharmacokinet. 2011;26(4):374-386.

2. 身体合併症を有する精神疾患患者の薬学的管理について
岩切 詩子, 仙波 純一, 末永 啓二, 島添 隆雄
薬学雑誌, 2011;131(4):493-496.


2010年

1. Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.
Hamamura M, Ozawa H, Ozaki M, Shimazoe T, Terada Y, Fukumaki Y.
J Neural Transm (Vienna). 2010;117(9):1041-1053.

2. Down-regulation of RhoA is involved in the cytotoxic action of lipophilic statins in HepG2 cells.
Maeda A, Yano T, Itoh Y, Kakumori M, Kubota T, Egashira N, Oishi R.
Atherosclerosis. 2010;208(1):112-118.

3. コーヒー飲料による糖代謝マーカーの改善に関する臨床研究 ―唾液中カフェイン濃度測定の妥当性―
岡田 知子, 小林 大介, 古野 純典, 島添 隆雄
薬学雑誌, 2010;130(5):713-5.

4. WarfarinとS-1併用患者における血液凝固能異常の発現時期に関する検討
山田 孝明, 渡邉 裕之, 矢野 貴久, 野中 敏治, 高田敦史, 園田 正信, 窪田 敏夫, 江頭 伸昭, 大石 了三
薬学雑誌, 2010;130(7):955-960.


2009年

1. Circadian trafficking of calbindin-ir in fibers of SCN neurons.
LeSauter J, Bhuiyan T, Shimazoe T, Silver R.
J Biol Rhythms. 2009;24(6):488-496.

2. Maternal exposure to dioxin disrupts gonadotropin production in fetal rats and imprints defects in sexual behavior.
Takeda T, Matsumoto Y, Koga T, Mutoh J, Nishimura Y, Shimazoe T, Ishii Y, Ishida T, Yamada H.
J Pharmacol Exp Ther. 2009;329(3):1091-1099.

3. Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy.
Kawashiri T, Egashira N, Itoh Y, Shimazoe T, Ikegami Y, Yano T, Yoshimura M, Oishi R.
Eur J Cancer. 2009;45(1):154-163.

4. 精神疾患を有する患者に対する薬学的管理について,
岩切 詩子、末永 啓二、島添 隆雄、小畑 寛幸,
九州薬学会会報, 2009;63:55-57.


2008年

1. Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum.
Hamamura M, Hirata N, Sawada K, Shuto T, Shimazoe T, Terada Y, Fukumaki Y.
J Neural Transm (Vienna). 2008;115(7):959-971.

2. Cholecystokinin-A receptors regulate photic input pathways to the circadian clock.
Shimazoe T, Morita M, Ogiwara S, Kojiya T, Goto J, Kamakura M, Moriya T, Shinohara K, Takiguchi S, Kono A, Miyasaka K, Funakoshi A, Ikeda M.
FASEB J. 2008;22(5):1479-1490.

3. Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea
Tanaka M, Kobayashi D, Murakami Y, Ozaki N, Suzuki T, Iwata N, Haraguchi K, Ieiri I, Kinukawa N, Hosoi M, Ohtani H, Sawada Y, Mine K.
Int J Neuropsychopharmacol. 2008;11(2):261-267.

4. 抗MRSA薬の適正使用を目指した薬物血中濃度モニタリング実施率向上への取り組み
窪田 敏夫、野中 敏治、矢野 貴久、住村 智子、林 純、伊藤 善規、大石 了三
日本病院薬剤師会雑誌, 2008;44(2):277-280.